T ype I interferons are central components of the early immune response not only restricted to the defense against viral infections. Recent findings place them at the interface between innate and adaptive immunity where they have an important role during diverse infections (1, 2) . The type I interferons, which comprise a single IFN␤ and more than a dozen IFN␣ subtypes (3), share the same type I IFN receptor (IFN␣/␤R). The canonical pathway for IFN␣/␤ production is initiated by IFN␤ induced by IFN regulatory factor (IRF)-3, which activates a positive feedback loop by means of the IFN␣/␤R and IRF-7. The amplification loop, in turn, leads to the production of other type I interferons and IFN-inducible genes (1) .
A wide variety of cells have been reported to express IFN␤ in vitro, including fibroblasts, epithelial cells, natural killer (NK) cells, macrophages (M⌽s), and dendritic cells (DCs) (1, 2) . Multiple mechanisms have been postulated to influence the differential expression of type I IFNs. Among these are activating or suppressing cytokines, specific migration patterns of DC subtypes, or local conditions within various anatomical compartments (4, 5) .
Plasmacytoid (p) DCs produce high amounts of IFN␣/␤ immediately after stimulation by means of the Toll-like receptors (TLRs) 7 and 9. The molecular basis for this phenomenon was shown to be an increased basal level of IRF-7 in pDCs, with TLR7 and 9 located at the endosomal membrane as preformed complexes together with their downstream signaling molecules, MyD88 and TRAF6 (6) (7) (8) . Therefore, these cells are able to produce in addition to IFN␤ also directly the IFN␣ subtypes independent of IRF-3 and the IFN␣/ ␤R-dependent positive feedback loop.
The contribution of each cell type to the production of type I IFNs in vivo in response to stimulation with defined molecular pathogen compounds that target different TLR pathways remains to be determined. Also, the in vivo role of the different candidate cell types responsible for the initial IFN␤ production in a viral infection setting is still largely unknown. The multitude of postulated IFN␤-producing cells underscores the need to identify which cells produce this cytokine under physiologic conditions. Thus, studies have been restricted to the detection of IFN␤ by bioassays or ELISAs. Intracellular staining can be done for total type I IFN, but because of the lack of suitable tools or detection reagents, it has not been possible to visualize IFN␤-secreting cells with the sensitivity necessary for in vivo experiments.
A recent report focused on the visualization of IFN␣-producing cells in vivo by replacing the gene for IFN␣6 with a GFP reporter gene (9) . IFN␣6 transcription is regulated by IRF-7 and, thus, represents the ''second wave'' of type I IFNs produced in most cells in the course of the positive feed back loop, whereas IFN␤ (as well as IFN␣4) can be activated by IRF-3 in addition to IRF-7 (10) . In that study, the authors showed that after systemic in vivo stimulation with TLR7 and TLR9 ligands splenocytes with a surface phenotype of pDCs were the main producers of IFN␣6, whereas injection of the TLR3/MDA-5 ligand poly(I:C) induced IFN␣ expression in non-pDCs. In both cases, the percentage of GFP ϩ cells was Ͻ0.5% of all splenocytes. Systemic i.v. injection of Newcastle disease virus, a negative-strand RNA virus, led to GFP expression mostly in pDCs as well as some conventional DCs. In contrast, after intranasal application, alveolar M⌽s and conventional DCs were the main IFN␣6-producing cells. Thus, distinct cell populations may mount a type I IFN response depending on the route of infection.
Here, we report the generation of an IFN␤/yellow fluorescent protein (YFP) knockin mouse, and present evidence that this reporter mouse represents a reliable tool for analyzing IFN␤ expression on a cellular level in vivo. After stimulation with defined molecular pathogen compounds, a clear dichotomy in in vitro Flt3-L-cultured bone marrow-derived (BM)DCs was observed with mainly the B220 ϩ CD11b Ϫ pDC subpopulation responding to 3Ј5Ј-cytidylylguanosine (CpG) oligodesoxynucleotide (ODN) stimulation, and the B220 Ϫ CD11b ϩ DC subpopulation from the same culture responding to stimulation with poly(I:C). In vivo, IFN␤ expression was activated by poly(I:C) predominantly in cells with the surface phenotype of activated CD8␣ ϩ conventional DCs, which accumulated in the red pulp and marginal zone in the spleen. In contrast, stimulation with CpG ODN induced IFN␤/YFP ϩ expression in pDCs, which were located in the splenic white pulp at the border of the T cell and B cell areas. The IFN␤-producing cellular subset defined in a mouse viral infection model by using murine cytomegalovirus showed identical phenotypic characteristics to the IFN␤-producers activated by CpG ODN.
Results
Generation of mob Mice. We generated a YFP knockin targeting vector such that an internal ribosomal entry site (IRES)-linked enhanced YFP fluorescence cassette was inserted into the endogenous ifnb locus immediately behind the STOP codon of the ifnb ORF (Fig. S1A) . By relying on the endogenous polyadenylation signal and regulatory elements in the 3Ј-untranslated region (11), we preserved any posttranscriptional regulation of the bicistronic message from the reporter allele in analogy to the WT ifnb transcript. The usage of embryonic stem (ES) cells, which express the Cre recombinase under control of the germ line specific protamine promoter, allowed for the Cre-mediated deletion of the floxed neomycin gene from the male germ line (12) . ES cell clones were screened by Southern blotting for correct integration of the construct (Fig. S1B) , and 2 independently targeted ES cell clones were injected into C57BL/6 blastocysts. Chimeric males were bred to C57BL/6 females and offspring screened for the presence of the mutated allele and the absence of the neomycin resistance cassette and the Cre transgene. The targeted allele was termed mob (messenger of IFN beta). Mob mice derived from both ES cell clones proved healthy, fertile, exhibited no obvious phenotype and showed identical YFP expression patterns. Simultaneous stimulation with different TLR agonists may suppress or synergize a particular immune response (13) . Therefore, we stimulated BMM⌽s and BMDCs with single molecular pathogen constituents known to produce type I IFNs and compared the IFN␤ production to simultaneous stimulations with combinations of several TLR ligands. For example, because the response to CpGs was shown to be bell shaped (14) , a range of concentrations was tested and the stimuli were used at optimal concentrations (data not shown). In BMM⌽s, no significant amount of YFP ϩ cells was detectable after stimulation with the TLR7 ligand R848 or type A or type B CpG ODN represented here by CpG 2216 (8) and CpG 1668 (15) , respectively ( Fig. 1A and Fig. S3C ). The most potent single stimulus was poly(I:C), which induced IFN␤ production in Ϸ15% of the cells, followed by LPS, which activated IFN␤/YFP expression in Ϸ1% of BMM⌽s ( Fig. 1 A and Fig. S3C ). Although pairwise combination of most stimuli neither enhanced nor attenuated IFN␤ production in BMM⌽s as compared with single stimuli, we observed a highly synergistic activation of IFN␤ expression (Ϸ25% YFP ϩ cells) by simultaneous incubation of these cells with poly(I:C) and the B type CpG 1668 ( Fig. 1 A and Fig. S3C) . Interestingly, combination of poly(I:C) and the A type ODN CpG 2216 had an inhibitory effect on IFN␤ induction with Ϸ6% of cells being YFP ϩ , only half of the percentage induced by stimulation with poly(I:C) alone ( Fig. 1 A and Fig. S3C ).
Applying the same panel of single and combined stimuli to BMDCs showed a different picture. Here, the highest frequency of IFN␤/YFP ϩ cells for a single stimulus was observed by using CpG 2216, whereas Ϸ1% of BMDCs became YFP ϩ after coincubation with either CpG 1668, poly(I:C), or LPS (Fig. 1B and Fig. S3D) . As for BMM⌽s, no IFN␤-producing cells were detected after stimulation of BMDCs with R848. In BMDCs, a synergistic induction of IFN␤ expression was found after simultaneous stimulation with CpG 2216 and poly(I:C) with LPS and either CpG ODN, but not for the combination of CpG 1668 with poly(I:C). An inhibitory effect on IFN␤ production was shown for CpG 2216 and R848 (Fig. 1B and Fig. S3D) .
pDCs, also called the natural IFN producing cells, were found to be highly efficient producers of type I IFN. Therefore, we tested BM-derived Flt3-L cultured cells for their ability to produce IFN␤ in response to different molecular pathogen compounds. Interestingly, a clear dichotomy in the IFN␤ response was observed from CD11b ϩ B220
Ϫ versus CD11b Ϫ B220 ϩ cells (the latter being phenotypically more similar to bona fide pDCs, as the CD11b Ϫ B220 ϩ cells also express Ly6C and mPDCA-1; data not shown) within the CD11c ϩ cell population derived from these Flt3-L cultures (16) . The type-A as well as type-B CpG ODNs induced IFN␤/YFP expression predominantly in the B220 ϩ CD11b Ϫ subpopulation ( Fig. 2A) . In marked contrast, LPS and poly(I:C) led to IFN␤ production almost exclusively in CD11b ϩ B220 Ϫ cells ( Fig.  2A) . The dichotomous IFN␤ production by these 2 pDC subpopulations was even more pronounced when CpG ODN was complexed to N- [1-(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP); here, a Ϸ10-fold increase in the frequency of IFN␤/YFP ϩ cells could be observed in response to CpG 1668, and a 2-fold increase to CpG 2216 (Fig. 2B) . (Fig. 3 A and C) with the response induced by the TLR9 ligand CpG 1668 (Fig. 3 B and D) ; i.v. challenge with any of these stimuli induced IFN␤/YFP expression in IFN␤ mob/mob mice predominantly in CD11c ϩ splenocytes (Fig. 3  A and B) or LN cells starting at 6 h and increasing through 24 h (data not shown). After poly(I:C) administration, Ϸ1% of the CD11c ϩ cells were positive for YFP, which equals Ϸ50,000 IFN␤-producing cells in total per spleen. The majority of these IFN␤ producers in the spleen or LNs expressed CD8␣, but not CD11b or the pDC marker mPDCA-1 (Fig. 3A and data not shown) . When CpG ODN was injected, IFN␤-producing cells from spleens and LNs were found predominantly within the CD11b Ϫ mPDCA-1 ϩ
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ϩ subpopulation of activated pDCs and accounted for up to 0.8% of CD11c ϩ cells in the spleen (Fig. 3B) . Of note, few IFN␤ producing cells were found to express CD11b. Costainings placed these cells within the mPDCA-1 hi DC subpopulation; thus, indicating an up to now unknown surface marker expression pattern. The exact morphological and functional phenotype of these cells remains unknown. No YFP fluorescence was detectable after either poly(I:C) or CpG ODN injection in WT control mice (Fig. 3 A and  B Upper) , or in IFN␤ mob/mob mice within populations of CD3 ϩ or CD19 ϩ lymphocytes or in DX5 ϩ cells, a shared marker for NK, NKT, or IFN-producing killer DCs cells (data not shown). When we analyzed the relative localization of the respective IFN␤/YFP ϩ cells in secondary lymphoid organs, we found these cells almost exclusively in the red pulp of the spleen and in the LN predominantly in the paracortex, but also in the region of the subcapsular sinus at 12 h after poly(I:C) administration (Fig. 3C) . Although in the LNs this localization remained unchanged after 24 h of poly(I:C) stimulation, in the spleen IFN␤-producing cells accumulated in the marginal zone with few cells appearing in the T cell zone of the white pulp. Costaining with specific marginal zone markers defined the position of the IFN␤-expressing cells more precisely beyond the rim of MOMA-1 ϩ metallophilic macrophages and the PNA ϩ marginal sinus, within the rim of ER-TR9 ϩ marginal zone M⌽s (Fig. S4 and data not shown). However, additional FACS analyses showed the cells to be negative for this marginal zone M⌽ marker (data not shown). Compared with this challenge with the TLR3/MDA-5 agonist poly(I:C), cells positive for YFP after treatment with CpG ODN were found at the interface of the T cell and B cell areas of the splenic white pulp as well as of the LNs (Fig. 3D) . No differences in localization were observed between the 12 h and the 24 h time points. Also, YFP ϩ cells in these histological stainings showed coexpression of B220, and were found to be smaller in cell size further corroborating the surface phenotype of these cells as pDCs (Fig. 3D ).
Phenotype and Frequency of IFN␤-Producing Cells During MCMV
Infection in Vivo. Type I interferons are key cytokines in the immune defense against viruses, including MCMV. KO mice lacking the IFN␣/␤R are highly susceptible to MCMV as compared with WT controls (17) . To define the identity of the cells responsible for the IFN␤ production as an early type I IFN required for a successful immune response against this virus, we infected IFN␤ mob/mob or WT mice i.p. with 10 6 cfu of MCMV. At 12 h and 24 h after infection, the vast majority of IFN␤-producing spleen cells showed intermediate expression of CD11c by FACS analysis (Fig. 4 A and B data not shown (Fig. 4B) . Immunofluorescence microscopy revealed positioning of the IFN␤/YFP ϩ cells predominantly at the T cell-B cell interface of the splenic white pulp, with few IFN␤-producing cells localizing to the red pulp or the marginal zone (Fig. 4C ). In accordance with the FACS analyses, immunohistological stainings showed YFP ϩ cells also to express B220 (Fig. 4C ).
Discussion
Although IFN␤ responses have been analyzed before by quantifying cytokine amounts in tissues or cell culture supernatants by ELISA, the definition of the identity and frequency of the cells responsible for the production of these cytokine amounts was so far not possible. Using an internal ribosome entry site (IRES) driven YFP-reporter mouse model, we here present data indicating that efficient IFN␤ protein production is restricted to a relatively low percentage of cells even within a homogenously stimulated cell population. Also, it could be shown that defined DC cell populations react to different TLR stimuli and exhibit a specialized localization and migration pattern after in vivo stimulation with molecular pathogen compounds. Without stimulation, no YFP was detectable in vitro or in vivo, arguing against efficient protein production from any constitutive IFN␤ mRNA in untreated cells (18) . The earliest time point YFP was detectable in vitro was Ϸ4 h after stimulation. Before emitting fluorescence, newly synthesized GFP polypeptides such as YFP need to mature in a process involving both folding and chromophore formation (19) . For YFP, the maturation takes 0.5-2 h. Taking these maturation requirements into account, the earliest time point for IFN␤ protein production lies between 2 and 4 h, in close agreement with measurements of serum IFN␤ after virus infection or TLR agonist administration in vivo (20) . Molecular pathogen compounds present in the exogenous milieu are sensed by membraneassociated pattern recognition receptors such as TLRs. Although many TLRs share common signaling pathways, a specific immune response may arise in response to distinct TLR agonists depending on the TLR-associated adaptor proteins and factors that modulate the signaling cascades (21) . Indeed, simultaneous targeting of the MyD88-dependent TLR9 pathway by CpG 1668 and the MyD88-independent TLR3 pathway by poly(I:C), synergistically induced IFN␤ expression in BMM⌽s. Similar effects were reported for IL-6 and TNF production after in vitro stimulation of murine M⌽s with poly(I:C) and B-type CpG ODN (22) , or after in vivo challenge with the MyD88-independent TLR3 agonist poly(I:C) and the MyD88-dependent TLR2 agonist Pam3Cys (23) . However, inhibitory effects on IFN␤ production were shown for poly(I:C) and CpG 2216 in BMM⌽s and CpG 2216 and R848 in BMDCs, respectively. The latter example extends earlier reports on an interference of TLR9 signaling by TLR7 activation in pDCs (24) . Besides the interplay of the signaling pathways fed by different TLR ligands, altered availability of pathogen compounds to the respective TLR harboring intracellular compartments could be an alternative explanation. It is, for example, possible that signals induced by means of TLR9 change the kinetics of poly(I:C) uptake, thereby reducing the intracellular availability of this stimulus. Overall, these data hint at a cell type-specific activation pattern of IFN␤ in response to distinct PAMPs, having an important role in immune reactions to distinct classes of pathogens such as viruses, bacteria, or protozoans. For Flt3-L grown BM derived pDCs, the efficient induction of YFPfluorescence by the CpG 2216 indicates that like IFN␣ production IFN␤ expression is also optimized by the spatiotemporal sequestration of this A-type CpG ODN to the TLR9-containing endosomal compartment (25) . Type-B ODNs, which are normally weakly IFN␤-inducing, activated high-level IFN␤-production by administration as complexes with the cationic lipid DOTAP that targets the endosomal compartment (26) . After poly(I:C) administration in vivo, YFP ϩ DCs are CD8␣ ϩ and CD11b Ϫ . In accordance with this surface marker expression pattern, it has been reported that the poly(I:C) receptor TLR3 in vivo is found preferentially in CD8␣ ϩ DCs (27) . However, these findings are in contrast to our in vitro data from Flt3-L cultured BM-derived pDCs. There, IFN␤ production was induced by poly(I:C) in cells which were negative for the plasmacytoid marker B220, but positive for CD11b. In fact, it has been shown that CD11b ϩ cells from Flt3-L cultured BM share other functional features of the CD8␣ ϩ DCs found in vivo (28) . The in vivo relocalization of YFP ϩ cells from the red pulp via the marginal zone to the T cell area at Ϸ24 h after poly(I:C) stimulation is delayed, compared with the general redistribution of DCs after LPS treatment, where they are found in the splenic T cell zone by 6 h after injection (29) . Interestingly, after injection of CpG ODN, YFP ϩ pDCs localized to the splenic T and B cell zones, whereas pDCs as a whole were described before to cluster mostly in the marginal zone with only few cells present in the splenic T cell areas (30) . Taking these two independent observations into account, our data argue for a specialized migration pattern of IFN␤-expressing cells within the subpopulation of activated pDCs in response to activation with selective molecular patterns representative of different types of pathogens.
Extending our studies of the cellular IFN␤ response in vivo to a viral infection model, we analyzed the cellular IFN␤ response in mob mice after i.p. injection of MCMV. Although the spleen and the liver are major sites of viral replication after this viral infection, YFP ϩ cells were only detectable in the spleen. However, IFN␤ mRNA expression levels are 1,000-fold lower in the liver, as compared with the spleen (31) . In light of these findings and with the already low frequencies of YFP/IFN␤ ϩ cells (Ͻ0.1%) taken into account, the presence of potential IFN␤-producing cells in the liver cannot be excluded but might be below the detection level. Earlier studies showed the presence of total type I IFN cytokine after MCMV infection in the red pulp areas of the spleen (32), whereas in this study most IFN␤ producing cells localized to the T cell/B cell border of the white pulp. These discrepancies indicate that distinct cell populations are responsible for the production of IFN␤ versus the IFN␣ subclasses even though the surface phenotype of IFN␤-producing cells matches the one described for cells producing also other type I IFNs after isolation from MCMV infected mice (32) (33) (34) . Although it has been shown that MCMV can actively infect macrophages and conventional DCs (34, 35) , infection rates of pDCs are very low (34) . Based on these findings, we speculate that the immunorelevant IFN␤-producing cells are not actually infected with the virus, which is consistent with the many immunosuppressive mechanisms used by MCMV (36). 
